This inventor holds 5 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignee: Novartis Ag. Active years: 2017-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2026
Title: **Innovative Contributions of Karthinathan Thangavelu in the Field of Medical Treatments**
Introduction
Karthinathan Thangavelu is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of medical treatments through his innovative patents. With a total of three patents to his name, Thangavelu focuses on utilizing Interleukin-17 (IL-17) antagonists to address specific inflammatory arthritis conditions.
Latest Patents
Thangavelu's latest patents include two critical methods for treating ankylosing spondylitis and psoriatic arthritis using IL-17 antagonists. The first patent describes novel regimens that employ a therapeutically effective amount of an IL-17 binding molecule or IL-17 receptor binding molecule, such as secukinumab. This treatment approach aims to alleviate symptoms associated with inflammatory arthritis, specifically targeting ankylosing spondylitis. Similarly, his second patent details treatments for psoriatic arthritis, employing the same innovative methodologies to improve patient outcomes.
Career Highlights
At Novartis Ag, a leading global healthcare company, Thangavelu has played a crucial role in the development of transformative medical therapies. His expertise in immunology and dedication to research have established him as a prominent figure in the medical innovation landscape. The work conducted at Novartis Ag combines his scientific acumen with real-world applications, particularly in treating inflammatory conditions.
Collaborations
Karthinathan Thangavelu has collaborated with talented coworkers such as Shephard Mpofu and Hanno Richards. This teamwork fosters a synergy that drives their research efforts and enhances the impact of their innovations in the medical field. Together, they tackle complex challenges, paving the way for new treatment modalities.
Conclusion
Karthinathan Thangavelu stands out as a leading inventor, contributing significantly to the treatment of inflammatory arthritis. With his pioneering patents and collaborations at Novartis Ag, he continues to influence the future of medical therapies. His innovative spirit and commitment to improving patient care make him an essential figure in the landscape of medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile